A multi-centre, double-blind randomized study to assess the efficacy and tolerance of sulindac versus placebo in the symptomatic treatment of patients with upper respiratory tract infection

D. L. Ebel Clinical Research International, Merck Sharp & Dohme Research Corporation, Rahway, PA, USA

W. J. Shih Clinical Biostatistics International, Merck Sharp & Dohme Research Corporation, Rahway, PA, USA

A. R. Rhymer Clinical Research International, Merck Sharp & Dohme Research Corporation, Rahway, PA, USA

References

Admani A. K., Verma S. A study of sulindac versus ibuprofen in elderly patients with osteoarthritis. Curr. Med. Res. Opin. 1983; 8: 3151. Admani A. K., Verma S. A study of sulindac versus ibuprofen in elderly patients with osteoarthritis. Curr. Med. Res. Opin. 1983; 8: 315
PubMed Web of Science ®Google Scholar
Dieppe P. A., Bury M. C., Grahame R., Perara T. Sulindac in osteoarthrosis of the hip. Rheumatol. Rehabil. 1976; 15: 1122. Dieppe P. A., Bury M. C., Grahame R., Perara T. Sulindac in osteoarthrosis of the hip. Rheumatol. Rehabil. 1976; 15: 112
PubMedGoogle Scholar
Janke P., Williams P., Williams P., Diggins J. B. Sulindac versus piroxicam in the treatment of osteoarthritis. Curr. Med. Res. Opin. 1983; 8: 4343. Janke P., Williams P., Williams P., Diggins J. B. Sulindac versus piroxicam in the treatment of osteoarthritis. Curr. Med. Res. Opin. 1983; 8: 434
PubMed Web of Science ®Google Scholar
Rhymer A. R. Sulindac. Clin. Rheum. Dis. 1979; 5: 5534. Rhymer A. R. Sulindac. Clin. Rheum. Dis. 1979; 5: 553
Google Scholar
Simila S., Keinanen-Kiukaanniemi S., Kouvalainen K. Oral antipyretic therapy: evaluation of Clinoril as an antipyretic agent. Curr. Ther. Res. 1979; 26: 8285. Simila S., Keinanen-Kiukaanniemi S., Kouvalainen K. Oral antipyretic therapy: evaluation of Clinoril as an antipyretic agent. Curr. Ther. Res. 1979; 26: 828
Google Scholar
Van Arman C. G., Risley E. A., Nuss G. W., Duggan D. E., Hucker H. B. The pharmacology of sulindac, an anti-inflammatory indene. Scand. J. Rheumatol. 1975; 4(Suppl. 8)S04, 016. Van Arman C. G., Risley E. A., Nuss G. W., Duggan D. E., Hucker H. B. The pharmacology of sulindac, an anti-inflammatory indene. Scand. J. Rheumatol. 1975; 4(Suppl. 8)S04, 01
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A multi-centre, double-blind randomized study to assess the efficacy and tolerance of sulindac versus placebo in the symptomatic treatment of patients with upper respiratory tract infection

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A multi-centre, double-blind randomized study to assess the efficacy and tolerance of sulindac versus placebo in the symptomatic treatment of patients with upper respiratory tract infection

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date